COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China

Background The clinical characteristics of novel coronavirus disease (COVID‐2019) patients outside the epicenter of Hubei Province are less understood. Methods We analyzed the epidemiological and clinical features of all COVID‐2019 cases in the only referral hospital in Shenzhen City, China, from Ja...

Full description

Saved in:
Bibliographic Details
Published inAllergy (Copenhagen) Vol. 75; no. 7; pp. 1742 - 1752
Main Authors Cai, Qingxian, Huang, Deliang, Ou, Pengcheng, Yu, Hong, Zhu, Zhibin, Xia, Zhang, Su, Yinan, Ma, Zhenghua, Zhang, Yiming, Li, Zhiwei, He, Qing, Liu, Lei, Fu, Yang, Chen, Jun
Format Journal Article
LanguageEnglish
Published Denmark Blackwell Publishing Ltd 01.07.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background The clinical characteristics of novel coronavirus disease (COVID‐2019) patients outside the epicenter of Hubei Province are less understood. Methods We analyzed the epidemiological and clinical features of all COVID‐2019 cases in the only referral hospital in Shenzhen City, China, from January 11, 2020, to February 6, 2020, and followed until March 6, 2020. Results Among the 298 confirmed cases, 233 (81.5%) had been to Hubei, while 42 (14%) did not have a clear travel history. Only 218 (73.15%) cases had a fever as the initial symptom. Compared with the nonsevere cases, severe cases were associated with older age, those with underlying diseases, and higher levels of C‐reactive protein, interleukin‐6, and erythrocyte sedimentation rate. Slower clearance of the virus was associated with a higher risk of progression to critical condition. As of March 6, 2020, 268 (89.9%) patients were discharged and the overall case fatality ratio was 1.0%. Conclusions In a designated hospital outside Hubei Province, COVID‐2019 patients could be effectively managed by properly using the existing hospital system. Mortality may be lowered when cases are relatively mild, and there are sufficient medical resources to care and treat the disease. This study analyzes the epidemiological and clinical features of all 298 COVID‐19 cases in the only referral hospital of Shenzhen City. Slower clearance of virus is associated with a higher progression to severe critical condition. Compared with the nonsevere cases, severe cases are associated with older age, underlying diseases, higher levels of C‐reactive protein, interleukin‐6, and erythrocyte sedimentation rate. Abbreviations: CRP, C‐reactive protein; ESR, erythrocyte sedimentation rate.
AbstractList The clinical characteristics of novel coronavirus disease (COVID-2019) patients outside the epicenter of Hubei Province are less understood.BACKGROUNDThe clinical characteristics of novel coronavirus disease (COVID-2019) patients outside the epicenter of Hubei Province are less understood.We analyzed the epidemiological and clinical features of all COVID-2019 cases in the only referral hospital in Shenzhen City, China, from January 11, 2020, to February 6, 2020, and followed until March 6, 2020.METHODSWe analyzed the epidemiological and clinical features of all COVID-2019 cases in the only referral hospital in Shenzhen City, China, from January 11, 2020, to February 6, 2020, and followed until March 6, 2020.Among the 298 confirmed cases, 233 (81.5%) had been to Hubei, while 42 (14%) did not have a clear travel history. Only 218 (73.15%) cases had a fever as the initial symptom. Compared with the nonsevere cases, severe cases were associated with older age, those with underlying diseases, and higher levels of C-reactive protein, interleukin-6, and erythrocyte sedimentation rate. Slower clearance of the virus was associated with a higher risk of progression to critical condition. As of March 6, 2020, 268 (89.9%) patients were discharged and the overall case fatality ratio was 1.0%.RESULTSAmong the 298 confirmed cases, 233 (81.5%) had been to Hubei, while 42 (14%) did not have a clear travel history. Only 218 (73.15%) cases had a fever as the initial symptom. Compared with the nonsevere cases, severe cases were associated with older age, those with underlying diseases, and higher levels of C-reactive protein, interleukin-6, and erythrocyte sedimentation rate. Slower clearance of the virus was associated with a higher risk of progression to critical condition. As of March 6, 2020, 268 (89.9%) patients were discharged and the overall case fatality ratio was 1.0%.In a designated hospital outside Hubei Province, COVID-2019 patients could be effectively managed by properly using the existing hospital system. Mortality may be lowered when cases are relatively mild, and there are sufficient medical resources to care and treat the disease.CONCLUSIONSIn a designated hospital outside Hubei Province, COVID-2019 patients could be effectively managed by properly using the existing hospital system. Mortality may be lowered when cases are relatively mild, and there are sufficient medical resources to care and treat the disease.
BackgroundThe clinical characteristics of novel coronavirus disease (COVID‐2019) patients outside the epicenter of Hubei Province are less understood.MethodsWe analyzed the epidemiological and clinical features of all COVID‐2019 cases in the only referral hospital in Shenzhen City, China, from January 11, 2020, to February 6, 2020, and followed until March 6, 2020.ResultsAmong the 298 confirmed cases, 233 (81.5%) had been to Hubei, while 42 (14%) did not have a clear travel history. Only 218 (73.15%) cases had a fever as the initial symptom. Compared with the nonsevere cases, severe cases were associated with older age, those with underlying diseases, and higher levels of C‐reactive protein, interleukin‐6, and erythrocyte sedimentation rate. Slower clearance of the virus was associated with a higher risk of progression to critical condition. As of March 6, 2020, 268 (89.9%) patients were discharged and the overall case fatality ratio was 1.0%.ConclusionsIn a designated hospital outside Hubei Province, COVID‐2019 patients could be effectively managed by properly using the existing hospital system. Mortality may be lowered when cases are relatively mild, and there are sufficient medical resources to care and treat the disease.
The clinical characteristics of novel coronavirus disease (COVID-2019) patients outside the epicenter of Hubei Province are less understood. We analyzed the epidemiological and clinical features of all COVID-2019 cases in the only referral hospital in Shenzhen City, China, from January 11, 2020, to February 6, 2020, and followed until March 6, 2020. Among the 298 confirmed cases, 233 (81.5%) had been to Hubei, while 42 (14%) did not have a clear travel history. Only 218 (73.15%) cases had a fever as the initial symptom. Compared with the nonsevere cases, severe cases were associated with older age, those with underlying diseases, and higher levels of C-reactive protein, interleukin-6, and erythrocyte sedimentation rate. Slower clearance of the virus was associated with a higher risk of progression to critical condition. As of March 6, 2020, 268 (89.9%) patients were discharged and the overall case fatality ratio was 1.0%. In a designated hospital outside Hubei Province, COVID-2019 patients could be effectively managed by properly using the existing hospital system. Mortality may be lowered when cases are relatively mild, and there are sufficient medical resources to care and treat the disease.
Background The clinical characteristics of novel coronavirus disease (COVID‐2019) patients outside the epicenter of Hubei Province are less understood. Methods We analyzed the epidemiological and clinical features of all COVID‐2019 cases in the only referral hospital in Shenzhen City, China, from January 11, 2020, to February 6, 2020, and followed until March 6, 2020. Results Among the 298 confirmed cases, 233 (81.5%) had been to Hubei, while 42 (14%) did not have a clear travel history. Only 218 (73.15%) cases had a fever as the initial symptom. Compared with the nonsevere cases, severe cases were associated with older age, those with underlying diseases, and higher levels of C‐reactive protein, interleukin‐6, and erythrocyte sedimentation rate. Slower clearance of the virus was associated with a higher risk of progression to critical condition. As of March 6, 2020, 268 (89.9%) patients were discharged and the overall case fatality ratio was 1.0%. Conclusions In a designated hospital outside Hubei Province, COVID‐2019 patients could be effectively managed by properly using the existing hospital system. Mortality may be lowered when cases are relatively mild, and there are sufficient medical resources to care and treat the disease. This study analyzes the epidemiological and clinical features of all 298 COVID‐19 cases in the only referral hospital of Shenzhen City. Slower clearance of virus is associated with a higher progression to severe critical condition. Compared with the nonsevere cases, severe cases are associated with older age, underlying diseases, higher levels of C‐reactive protein, interleukin‐6, and erythrocyte sedimentation rate. Abbreviations: CRP, C‐reactive protein; ESR, erythrocyte sedimentation rate.
Author Ma, Zhenghua
Li, Zhiwei
Chen, Jun
Fu, Yang
Zhang, Yiming
He, Qing
Huang, Deliang
Su, Yinan
Yu, Hong
Liu, Lei
Cai, Qingxian
Zhu, Zhibin
Ou, Pengcheng
Xia, Zhang
Author_xml – sequence: 1
  givenname: Qingxian
  surname: Cai
  fullname: Cai, Qingxian
  organization: The Second Affiliated Hospital of Southern University of Science and Technology
– sequence: 2
  givenname: Deliang
  surname: Huang
  fullname: Huang, Deliang
  organization: The Second Affiliated Hospital of Southern University of Science and Technology
– sequence: 3
  givenname: Pengcheng
  surname: Ou
  fullname: Ou, Pengcheng
  organization: The First Affiliated Hospital of Southern University of Science and Technology
– sequence: 4
  givenname: Hong
  surname: Yu
  fullname: Yu, Hong
  organization: The Second Affiliated Hospital of Southern University of Science and Technology
– sequence: 5
  givenname: Zhibin
  surname: Zhu
  fullname: Zhu, Zhibin
  organization: The Second Affiliated Hospital of Southern University of Science and Technology
– sequence: 6
  givenname: Zhang
  surname: Xia
  fullname: Xia, Zhang
  organization: The Second Affiliated Hospital of Southern University of Science and Technology
– sequence: 7
  givenname: Yinan
  surname: Su
  fullname: Su, Yinan
  organization: Southern University of Science and Technology
– sequence: 8
  givenname: Zhenghua
  surname: Ma
  fullname: Ma, Zhenghua
  organization: The Second Affiliated Hospital of Southern University of Science and Technology
– sequence: 9
  givenname: Yiming
  surname: Zhang
  fullname: Zhang, Yiming
  organization: The Second Affiliated Hospital of Southern University of Science and Technology
– sequence: 10
  givenname: Zhiwei
  surname: Li
  fullname: Li, Zhiwei
  organization: The Second Affiliated Hospital of Southern University of Science and Technology
– sequence: 11
  givenname: Qing
  surname: He
  fullname: He, Qing
  organization: The Second Affiliated Hospital of Southern University of Science and Technology
– sequence: 12
  givenname: Lei
  surname: Liu
  fullname: Liu, Lei
  email: liulei3322@aliyun.com
  organization: The Second Affiliated Hospital of Southern University of Science and Technology
– sequence: 13
  givenname: Yang
  surname: Fu
  fullname: Fu, Yang
  email: fuy@sustech.edu.cn
  organization: Southern University of Science and Technology
– sequence: 14
  givenname: Jun
  orcidid: 0000-0002-9744-792X
  surname: Chen
  fullname: Chen, Jun
  email: drchenjun@163.com
  organization: The Second Affiliated Hospital of Southern University of Science and Technology
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32239761$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1KxDAUhYMoOo4ufAEJuFGwmt9ps5TxZ4QBXajbkCa3GumkY9Mq7nwEn9EnMTrqQtC7uVz4zuFyzjpaDk0AhLYoOaBpDk1dH1DBiVpCA8pVkSml5DIaEEpkJiQv1tB6jPeEkJwpsorWOGNc5SM6QNfji5vz47eXV6qwD9hgB9HfBtOBS3cFtvNNH7HzEUyEiO-aOPedqXHTd9E7wJO-BI8v2-bRBwv7eHzng9lAK5WpI2x-7SG6Pj25Gk-y6cXZ-fhomllRMJVJLpRjShgKfERNKXNDrFSFLYFzk1ecSwkgqVNOMOFGlaMlKwsnCselJcCHaHfhO2-bhx5ip2c-WqhrEyC9rRkvZE6KXNCE7vxC75u-Dek7zQRjgssR-6C2v6i-nIHT89bPTPusvwNLwN4CsG0TYwvVD0KJ_ihDpzL0ZxmJPfzF2hRdCjR0rfH1f4onX8Pz39b6aDpdKN4BNtSZGw
CitedBy_id crossref_primary_10_13105_wjma_v11_i1_5
crossref_primary_10_3851_IMP3385
crossref_primary_10_1039_D0AY02304C
crossref_primary_10_1186_s13018_020_01702_w
crossref_primary_10_3390_jcm10194432
crossref_primary_10_35772_ghm_2020_01025
crossref_primary_10_1016_j_ajem_2020_08_089
crossref_primary_10_1186_s12872_020_01816_3
crossref_primary_10_1093_ndt_gfaa218
crossref_primary_10_1371_journal_pone_0250602
crossref_primary_10_1111_all_16028
crossref_primary_10_3748_wjg_v27_i15_1531
crossref_primary_10_15302_J_QB_020_0230
crossref_primary_10_4254_wjh_v16_i4_517
crossref_primary_10_1016_j_ajem_2020_08_090
crossref_primary_10_1111_all_14647
crossref_primary_10_3748_wjg_v28_i42_6017
crossref_primary_10_3390_vaccines11020460
crossref_primary_10_1080_10410236_2021_1991618
crossref_primary_10_7759_cureus_13894
crossref_primary_10_1515_almed_2022_0037
crossref_primary_10_12688_f1000research_53539_2
crossref_primary_10_7759_cureus_35426
crossref_primary_10_1136_bmjopen_2021_051534
crossref_primary_10_3748_wjg_v29_i16_2397
crossref_primary_10_3389_fcvm_2021_757799
crossref_primary_10_1002_hsr2_274
crossref_primary_10_1016_j_ijmmb_2021_04_007
crossref_primary_10_5468_ogs_20174
crossref_primary_10_1186_s12879_020_05728_7
crossref_primary_10_1016_j_heliyon_2020_e05684
crossref_primary_10_1136_bmjopen_2024_085971
crossref_primary_10_1111_all_15502
crossref_primary_10_1038_s41598_021_02982_w
crossref_primary_10_1097_CCM_0000000000004411
crossref_primary_10_5812_hepatmon_104415
crossref_primary_10_4103_NJM_NJM_142_20
crossref_primary_10_1002_jmv_26336
crossref_primary_10_1016_S2213_2600_21_00103_X
crossref_primary_10_1155_adph_4456532
crossref_primary_10_1016_S2213_2600_20_30404_5
crossref_primary_10_1080_20477724_2024_2313787
crossref_primary_10_1016_j_ajic_2020_08_013
crossref_primary_10_12688_f1000research_53539_1
crossref_primary_10_1186_s12879_021_05992_1
crossref_primary_10_1007_s13337_023_00818_x
crossref_primary_10_12998_wjcc_v9_i16_3814
crossref_primary_10_18632_aging_103383
crossref_primary_10_3390_medicina58121701
crossref_primary_10_7759_cureus_45389
crossref_primary_10_1177_22799036221115779
crossref_primary_10_1177_10815589231158041
crossref_primary_10_2147_IJGM_S327429
crossref_primary_10_3389_fmed_2021_588013
crossref_primary_10_1016_j_metabol_2020_154373
crossref_primary_10_1097_MD_0000000000023315
crossref_primary_10_14218_JCTH_2021_00368
crossref_primary_10_1007_s00415_020_09978_y
crossref_primary_10_1016_j_cmi_2020_07_016
crossref_primary_10_4081_monaldi_2021_1694
crossref_primary_10_3748_wjg_v29_i3_425
crossref_primary_10_1002_hsr2_1803
crossref_primary_10_1080_1120009X_2021_1988203
crossref_primary_10_17816_rmmar83626
crossref_primary_10_5114_pjr_2021_103379
crossref_primary_10_1136_jim_2021_001858
crossref_primary_10_1017_ice_2021_391
crossref_primary_10_5005_jp_journals_10024_3076
crossref_primary_10_1155_2023_9955105
crossref_primary_10_1161_CIRCEP_120_008740
crossref_primary_10_3748_wjg_v26_i19_2286
crossref_primary_10_12998_wjcc_v10_i7_2063
crossref_primary_10_3389_fphar_2020_01093
crossref_primary_10_3389_fmed_2020_00301
crossref_primary_10_3389_fmed_2020_00542
crossref_primary_10_4254_wjh_v13_i10_1215
crossref_primary_10_1177_2054358120938573
crossref_primary_10_3390_molecules26216614
crossref_primary_10_1186_s12985_023_02081_4
crossref_primary_10_4103_ijrh_ijrh_106_20
crossref_primary_10_1016_j_ajem_2020_10_022
crossref_primary_10_4103_jfmpc_jfmpc_2527_20
crossref_primary_10_1016_j_jhep_2020_04_042
crossref_primary_10_1111_all_14449
crossref_primary_10_3748_wjg_v27_i7_561
crossref_primary_10_1136_bmjopen_2020_039856
crossref_primary_10_1186_s12879_020_05252_8
crossref_primary_10_12688_f1000research_26186_2
crossref_primary_10_12998_wjcc_v9_i3_528
crossref_primary_10_12688_f1000research_26186_1
crossref_primary_10_1152_physrev_00010_2023
crossref_primary_10_3390_life14111376
crossref_primary_10_3389_fphar_2022_799338
crossref_primary_10_4103_jfmpc_jfmpc_138_22
crossref_primary_10_1111_jvh_13590
crossref_primary_10_1007_s11356_020_10132_4
crossref_primary_10_1038_s41421_020_00231_4
crossref_primary_10_1111_dth_13666
crossref_primary_10_1002_hep_31480
crossref_primary_10_1007_s12016_022_08921_5
crossref_primary_10_1111_all_14453
crossref_primary_10_1111_all_14452
crossref_primary_10_1590_1806_9282_66_s2_13
crossref_primary_10_1002_lt_26194
crossref_primary_10_3389_fpubh_2023_1003352
crossref_primary_10_1371_journal_pone_0253894
crossref_primary_10_1002_clc_23465
crossref_primary_10_1016_j_clon_2020_11_006
crossref_primary_10_3389_fcimb_2022_726263
crossref_primary_10_1055_s_0040_1714369
crossref_primary_10_1002_hep_32582
crossref_primary_10_3390_life14030343
crossref_primary_10_1007_s00148_022_00887_0
crossref_primary_10_1111_all_14465
crossref_primary_10_1155_2021_6594863
crossref_primary_10_1186_s43066_022_00171_6
crossref_primary_10_1136_postgradmedj_2021_139939
crossref_primary_10_11604_pamj_2024_49_2_44247
crossref_primary_10_1186_s12916_020_01726_3
crossref_primary_10_3947_ic_2020_52_3_317
crossref_primary_10_1080_10641963_2020_1867160
crossref_primary_10_1007_s40745_022_00378_9
crossref_primary_10_3389_fneur_2020_00687
crossref_primary_10_3389_fneur_2020_00565
crossref_primary_10_21467_ias_10_1_151_167
crossref_primary_10_3389_fpubh_2020_574915
crossref_primary_10_3390_vaccines11010048
crossref_primary_10_3748_wjg_v26_i22_2987
crossref_primary_10_1111_all_14472
crossref_primary_10_1080_14789450_2023_2191845
crossref_primary_10_1002_rmv_2195
crossref_primary_10_31146_1682_8658_ecg_191_7_6_11
crossref_primary_10_25259_ANAMS_1078_2023
crossref_primary_10_1016_j_jtumed_2022_02_002
crossref_primary_10_1038_s41598_021_88130_w
crossref_primary_10_1111_liv_15274
crossref_primary_10_1016_j_cmi_2020_12_018
crossref_primary_10_22516_25007440_713
crossref_primary_10_1111_ijcp_13725
crossref_primary_10_4103_JODP_JODP_16_20
crossref_primary_10_1155_2021_6671291
crossref_primary_10_1111_obr_13095
crossref_primary_10_14218_JCTH_2021_00055
crossref_primary_10_13105_wjma_v9_i2_108
crossref_primary_10_1136_bmjopen_2020_040129
crossref_primary_10_3748_wjg_v27_i28_4504
crossref_primary_10_3851_IMP3382
crossref_primary_10_1515_chem_2021_0049
crossref_primary_10_1111_jvh_13362
crossref_primary_10_12998_wjcc_v9_i22_6178
crossref_primary_10_1016_j_jinf_2020_06_067
crossref_primary_10_1038_s41598_022_16396_9
crossref_primary_10_7759_cureus_12039
crossref_primary_10_1155_2021_7830136
crossref_primary_10_3390_pathogens11040445
crossref_primary_10_1016_j_dsx_2021_102308
crossref_primary_10_1016_j_jfma_2021_05_015
crossref_primary_10_1155_2022_4291758
crossref_primary_10_3390_jcm10030446
crossref_primary_10_4103_ijpm_ijpm_658_21
crossref_primary_10_1186_s43066_021_00131_6
crossref_primary_10_13105_wjma_v8_i5_348
crossref_primary_10_1186_s12879_025_10456_x
crossref_primary_10_31590_ejosat_1113302
crossref_primary_10_3390_nu13062060
crossref_primary_10_1136_jclinpath_2020_207023
crossref_primary_10_7759_cureus_47028
crossref_primary_10_1002_rmv_2304
crossref_primary_10_1016_j_dsx_2020_11_011
crossref_primary_10_1097_MEG_0000000000002068
crossref_primary_10_1016_j_clinre_2021_101793
crossref_primary_10_1177_1934578X221142790
crossref_primary_10_1007_s10157_021_02123_7
crossref_primary_10_1111_dth_15521
crossref_primary_10_1080_19932820_2021_2010338
crossref_primary_10_1016_j_aohep_2020_10_001
crossref_primary_10_1155_2021_6658270
crossref_primary_10_1159_000513593
crossref_primary_10_1097_MCG_0000000000001432
crossref_primary_10_4103_singaporemedj_SMJ_2021_111
crossref_primary_10_13181_mji_oa_236992
crossref_primary_10_1055_s_0040_1721292
crossref_primary_10_1002_iid3_1020
crossref_primary_10_1186_s12941_021_00420_3
crossref_primary_10_1016_S2666_5247_20_30172_5
crossref_primary_10_17235_reed_2020_7397_2020
crossref_primary_10_3389_fped_2021_616381
crossref_primary_10_1111_sji_12967
crossref_primary_10_1016_j_cca_2020_06_009
crossref_primary_10_1155_2022_7405448
crossref_primary_10_12677_ACM_2021_115292
crossref_primary_10_12998_wjcc_v9_i23_6608
crossref_primary_10_36472_msd_v9i9_817
crossref_primary_10_3390_tropicalmed8020084
crossref_primary_10_1007_s10620_021_07007_0
crossref_primary_10_1186_s40001_023_01401_2
crossref_primary_10_12998_wjcc_v9_i27_7998
crossref_primary_10_1186_s13054_020_03062_7
crossref_primary_10_2147_IDR_S355742
crossref_primary_10_12998_wjcc_v9_i19_4969
crossref_primary_10_1002_jmv_26737
crossref_primary_10_1016_j_xkme_2020_11_008
crossref_primary_10_1177_1753466620963035
crossref_primary_10_1016_j_snb_2020_129333
crossref_primary_10_1109_ACCESS_2021_3108447
crossref_primary_10_1097_QAI_0000000000003399
crossref_primary_10_1016_j_dsx_2020_04_044
crossref_primary_10_1097_MD_0000000000033294
crossref_primary_10_2147_JPR_S269206
crossref_primary_10_1186_s12879_021_05847_9
crossref_primary_10_3389_fphar_2021_719308
crossref_primary_10_12998_wjcc_v8_i19_4303
crossref_primary_10_2174_0118749445339251241114094239
crossref_primary_10_58854_jicm_1510319
crossref_primary_10_1111_eci_13763
crossref_primary_10_2174_0126667975267776231117052825
crossref_primary_10_4103_1995_7645_315897
crossref_primary_10_4236_jct_2024_153009
crossref_primary_10_3201_eid2902_221098
crossref_primary_10_4103_kjo_kjo_204_21
crossref_primary_10_3389_fmed_2020_00458
crossref_primary_10_1016_j_sapharm_2020_04_032
crossref_primary_10_1017_S0950268820003027
crossref_primary_10_12998_wjcc_v10_i36_13148
crossref_primary_10_1183_13993003_00562_2020
crossref_primary_10_1016_j_ajem_2020_09_018
crossref_primary_10_1007_s00251_020_01179_1
crossref_primary_10_1097_MD_0000000000022971
crossref_primary_10_4081_monaldi_2021_1610
crossref_primary_10_3389_fmed_2021_629296
crossref_primary_10_1016_j_jiph_2021_02_011
crossref_primary_10_7759_cureus_29198
crossref_primary_10_1038_s41392_022_00907_1
crossref_primary_10_1002_edm2_338
crossref_primary_10_1111_ijlh_13336
crossref_primary_10_1097_RCT_0000000000001354
crossref_primary_10_1177_11772719221106600
crossref_primary_10_1038_s41366_021_00776_8
crossref_primary_10_1007_s12016_021_08908_8
crossref_primary_10_2139_ssrn_3951144
crossref_primary_10_1002_jcla_23483
crossref_primary_10_1016_j_gtc_2022_09_001
crossref_primary_10_1111_obr_13149
crossref_primary_10_2174_1381612827666210311141512
crossref_primary_10_2807_1560_7917_ES_2021_26_14_2001506
crossref_primary_10_1515_biol_2022_0502
crossref_primary_10_23736_S0026_4806_21_07809_5
crossref_primary_10_7759_cureus_9424
crossref_primary_10_1136_bmjopen_2020_044661
crossref_primary_10_54962_ankemderg_1163275
crossref_primary_10_1093_hmg_ddab125
crossref_primary_10_7759_cureus_11555
crossref_primary_10_3389_fmed_2020_00398
crossref_primary_10_13105_wjma_v9_i1_64
crossref_primary_10_1111_apt_15813
crossref_primary_10_4103_sjg_sjg_540_20
crossref_primary_10_1097_MD_0000000000026719
crossref_primary_10_1093_ofid_ofab201
crossref_primary_10_23736_S0031_0808_21_04239_7
crossref_primary_10_1002_jmv_26411
crossref_primary_10_1038_s41598_021_99470_y
crossref_primary_10_1097_MRM_0000000000000267
crossref_primary_10_1097_MD_0000000000028499
crossref_primary_10_1111_sji_13039
crossref_primary_10_1038_s41591_020_1025_y
crossref_primary_10_2147_IJGM_S320713
crossref_primary_10_12998_wjcc_v8_i16_3405
crossref_primary_10_3390_molecules25245905
crossref_primary_10_1177_01455613211038070
crossref_primary_10_4103_jpbs_jpbs_88_23
crossref_primary_10_1080_1120009X_2021_1899442
crossref_primary_10_3389_fmolb_2023_1164220
crossref_primary_10_1002_ygh2_455
crossref_primary_10_3390_biomedicines11113002
crossref_primary_10_1038_s41598_021_89513_9
crossref_primary_10_1515_almed_2022_0010
crossref_primary_10_1016_j_intimp_2023_110439
crossref_primary_10_1371_journal_pone_0265117
crossref_primary_10_1093_ckj_sfaa160
crossref_primary_10_1186_s41232_022_00205_x
crossref_primary_10_4103_jodp_jodp_46_23
crossref_primary_10_12998_wjcc_v11_i10_2189
crossref_primary_10_3748_wjg_v28_i46_6599
crossref_primary_10_1016_j_jceh_2021_05_003
crossref_primary_10_1089_jir_2022_0185
crossref_primary_10_13105_wjma_v9_i2_192
crossref_primary_10_13105_wjma_v9_i2_193
crossref_primary_10_3389_fcimb_2021_667487
crossref_primary_10_2174_18749445_v15_e2207290
crossref_primary_10_1111_hepr_13541
crossref_primary_10_1111_jan_14558
crossref_primary_10_3889_oamjms_2020_5380
crossref_primary_10_1002_aid2_13260
crossref_primary_10_1002_jmv_26314
crossref_primary_10_5114_amsad_2022_115008
crossref_primary_10_2147_IJGM_S347291
crossref_primary_10_1016_j_jhep_2020_06_041
Cites_doi 10.1016/j.jacc.2018.08.1038
10.1101/2020.01.23.20018549
10.1164/rccm.201908-1581ST
10.1056/NEJMoa2001316
10.1056/NEJMoa2001191
10.3201/eid1002.030741
10.1101/2020.02.03.931766
10.1016/j.coviro.2017.11.002
10.1001/jama.2020.1585
10.1056/NEJMoa2002032
10.1056/NEJMoa2001017
10.1016/S0140-6736(15)60454-8
10.3201/eid1002.030761
10.1016/S0140-6736(20)30183-5
10.1016/j.jhep.2019.02.014
ContentType Journal Article
Copyright 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
Copyright © 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Copyright_xml – notice: 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
– notice: Copyright © 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
DBID AAYXX
CITATION
NPM
7T5
H94
K9.
7X8
DOI 10.1111/all.14309
DatabaseName CrossRef
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
AIDS and Cancer Research Abstracts
PubMed

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1398-9995
EndPage 1752
ExternalDocumentID 32239761
10_1111_all_14309
ALL14309
Genre article
Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: Funds for the construction of key medical disciplines in Shenzhen
– fundername: Bill and Melinda Gates Foundation
– fundername: The National infectious diseases Clinical Research Center
– fundername: Sanming Project of Medicine in Shenzhen
  funderid: SZSM201612014
– fundername: Sanming Project of Medicine in Shenzhen
  grantid: SZSM201612014
GroupedDBID .3N
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
23M
24P
2WC
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8F7
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
AOETA
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
P6G
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
TR2
UB1
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
Y6R
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
NPM
7T5
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
H94
K9.
7X8
ID FETCH-LOGICAL-c4829-5349d294a1e361ab57a0c598cbe33a7f3355ee51d9d424d6fd1b2b8d48d35c0e3
IEDL.DBID DR2
ISSN 0105-4538
1398-9995
IngestDate Fri Jul 11 06:27:17 EDT 2025
Fri Jul 25 04:07:31 EDT 2025
Wed Feb 19 02:30:40 EST 2025
Thu Apr 24 23:11:51 EDT 2025
Tue Jul 01 04:15:13 EDT 2025
Wed Jan 22 16:34:05 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords severe pneumonia
epidemiological features
severe acute respiratory syndrome coronavirus 2
corona Virus Disease 2019
Language English
License 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4829-5349d294a1e361ab57a0c598cbe33a7f3355ee51d9d424d6fd1b2b8d48d35c0e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-9744-792X
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/all.14309
PMID 32239761
PQID 2422435621
PQPubID 34098
PageCount 11
ParticipantIDs proquest_miscellaneous_2385708741
proquest_journals_2422435621
pubmed_primary_32239761
crossref_primary_10_1111_all_14309
crossref_citationtrail_10_1111_all_14309
wiley_primary_10_1111_all_14309_ALL14309
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate July 2020
PublicationDateYYYYMMDD 2020-07-01
PublicationDate_xml – month: 07
  year: 2020
  text: July 2020
PublicationDecade 2020
PublicationPlace Denmark
PublicationPlace_xml – name: Denmark
– name: Zurich
PublicationTitle Allergy (Copenhagen)
PublicationTitleAlternate Allergy
PublicationYear 2020
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References 2004; 10
2018; 28
2019; 70
2020; 323
2018; 72
2020; 382
2020
2020; 395
2019; 200
2016; 68
2015; 386
e_1_2_9_11_1
Rossaint J (e_1_2_9_10_1) 2016; 68
National Health Commission of the People’s Republic of China (e_1_2_9_12_1)
e_1_2_9_13_1
e_1_2_9_8_1
e_1_2_9_7_1
e_1_2_9_6_1
e_1_2_9_5_1
e_1_2_9_4_1
e_1_2_9_3_1
e_1_2_9_2_1
e_1_2_9_9_1
e_1_2_9_15_1
e_1_2_9_14_1
e_1_2_9_17_1
e_1_2_9_16_1
e_1_2_9_19_1
e_1_2_9_18_1
References_xml – volume: 395
  start-page: 497
  year: 2020
  end-page: 506
  article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  publication-title: Lancet
– volume: 382
  start-page: 929
  issue: 10
  year: 2020
  end-page: 936
  article-title: First case of 2019 novel coronavirus in the United States
  publication-title: N Engl J Med
– year: 2020
  article-title: Clinical characteristics of coronavirus disease 2019 in China
  publication-title: N Engl J Med
– volume: 28
  start-page: 43
  year: 2018
  end-page: 52
  article-title: Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host
  publication-title: Curr Opin Virol
– volume: 72
  start-page: 2231
  issue: 18
  year: 2018
  end-page: 2264
  article-title: Fourth universal definition of myocardial infarction (2018)
  publication-title: J Am Coll Cardiol
– volume: 70
  start-page: 1222
  issue: 6
  year: 2019
  end-page: 2126
  article-title: EASL clinical practice guidelines: drug‐induced liver injury
  publication-title: J Hepatol
– volume: 386
  start-page: 995
  issue: 9997
  year: 2015
  end-page: 1007
  article-title: Middle East respiratory syndrome
  publication-title: Lancet
– year: 2020
– volume: 200
  start-page: e45
  year: 2019
  end-page: e67
  article-title: Diagnosis and treatment of adults with community‐acquired pneumonia: an official clinical practice guideline of the American Thoracic Society and Infectious Disease Society of America
  publication-title: Am J Respir Crit Care Med
– article-title: Specific ACE2 expression in cholangiocytes may cause liver damage after 2019‐nCoV infection
  publication-title: bioRxiv
– volume: 10
  start-page: 334
  issue: 2
  year: 2004
  end-page: 338
  article-title: Clinical description of a completed outbreak of SARS in Vietnam, February–May, 2003
  publication-title: Emerg Infect Dis
– volume: 68
  start-page: 49
  issue: 1
  year: 2016
  end-page: 57
  article-title: Acute kidney injury: definition, diagnosis and epidemiology
  publication-title: Minerva Urol Nefrol
– volume: 10
  start-page: 327
  issue: 2
  year: 2004
  end-page: 333
  article-title: Combining clinical and epidemiologic features for early recognition of SARS
  publication-title: Emerg Infect Dis
– volume: 382
  start-page: 727
  issue: 8
  year: 2020
  end-page: 733
  article-title: A novel coronavirus from patients with pneumonia in China, 2019
  publication-title: N Engl J Med
– volume: 323
  start-page: 1061
  issue: 11
  year: 2020
  end-page: 1069
  article-title: Clinical characteristics of 138 hospitalization patients with 2019 novel coronavirus‐infected pneumonia in Wuhan, China
  publication-title: JAMA
– volume: 382
  start-page: 1199
  year: 2020
  end-page: 1207
  article-title: Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia
  publication-title: N Engl J Med
– ident: e_1_2_9_11_1
  doi: 10.1016/j.jacc.2018.08.1038
– ident: e_1_2_9_2_1
– ident: e_1_2_9_4_1
  doi: 10.1101/2020.01.23.20018549
– ident: e_1_2_9_8_1
  doi: 10.1164/rccm.201908-1581ST
– ident: e_1_2_9_3_1
  doi: 10.1056/NEJMoa2001316
– ident: e_1_2_9_19_1
  doi: 10.1056/NEJMoa2001191
– ident: e_1_2_9_14_1
  doi: 10.3201/eid1002.030741
– ident: e_1_2_9_16_1
  doi: 10.1101/2020.02.03.931766
– ident: e_1_2_9_15_1
  doi: 10.1016/j.coviro.2017.11.002
– ident: e_1_2_9_6_1
  doi: 10.1001/jama.2020.1585
– ident: e_1_2_9_7_1
  doi: 10.1056/NEJMoa2002032
– ident: e_1_2_9_13_1
  doi: 10.1056/NEJMoa2001017
– ident: e_1_2_9_18_1
  doi: 10.1016/S0140-6736(15)60454-8
– volume: 68
  start-page: 49
  issue: 1
  year: 2016
  ident: e_1_2_9_10_1
  article-title: Acute kidney injury: definition, diagnosis and epidemiology
  publication-title: Minerva Urol Nefrol
– volume-title: Handbook of Prevention and Treatment of the Pneumonia Caused by the Novel Coronavirus (2019‐nCoV)
  ident: e_1_2_9_12_1
– ident: e_1_2_9_17_1
  doi: 10.3201/eid1002.030761
– ident: e_1_2_9_5_1
  doi: 10.1016/S0140-6736(20)30183-5
– ident: e_1_2_9_9_1
  doi: 10.1016/j.jhep.2019.02.014
SSID ssj0007290
Score 2.6883676
Snippet Background The clinical characteristics of novel coronavirus disease (COVID‐2019) patients outside the epicenter of Hubei Province are less understood. Methods...
The clinical characteristics of novel coronavirus disease (COVID-2019) patients outside the epicenter of Hubei Province are less understood. We analyzed the...
BackgroundThe clinical characteristics of novel coronavirus disease (COVID‐2019) patients outside the epicenter of Hubei Province are less understood.MethodsWe...
The clinical characteristics of novel coronavirus disease (COVID-2019) patients outside the epicenter of Hubei Province are less understood.BACKGROUNDThe...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1742
SubjectTerms corona Virus Disease 2019
Coronaviruses
COVID-19
epidemiological features
Epidemiology
Erythrocyte sedimentation rate
Fever
Hospitals
Infectious diseases
Patients
severe acute respiratory syndrome coronavirus 2
severe pneumonia
Title COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fall.14309
https://www.ncbi.nlm.nih.gov/pubmed/32239761
https://www.proquest.com/docview/2422435621
https://www.proquest.com/docview/2385708741
Volume 75
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1JT9wwFICfEIeKS0sLtAO0MhUHDg1KvCSxOCFaNCA2oU7FoVLkDYEYBcRMLj31J_Q39pfw7DgpW6Wqt0h-2Ww_-7P9FoB1l4vCMO9-xmmRcCNF4mfFRBbMyFQaroK72OFRPhzx_TNxNgNbnS9MGx-i33DzmhHGa6_gSk_uKbkaj1HNWXDe87ZaHohO_4SOKuL-CvJDwlGrY1Qhb8XT3_lwLnoCmA95NUw4u6_ge_eprZ3J1WYz1Zvmx6Mojv_5L_PwMoIo2W57zmuYcfUbeHEYj9oXYLRz_G3v8--fvzJJLmuiiA22HoimlnQWXM2ExAOeCbmICUjIdTP1KUDJsNHukpyELQvjPpGQqXsRRrtfvu4Mk5iDITG8pDIRjEtLJVeZY3mmtChUaoQsjXaMqeKcIa84JzIrLafc5uc201SXlpeWCZM6tgSz9XXt3gHhTEvJXYkEprgthBQonlLLtDD4SDeAja41KhMDlPs8GeOqW6hgNVWhmgbwsRe9aaNyPCe02jVpFRVzUiGRUCTEnGYDWOuLUaX8OYmqHdZchRQjirRE1hrA27Yr9G_B8c8THJZshAb9--ur7YODcLH876IrMEf9ej6YA6_C7PS2ce8Reqb6Q-jdd42w-ks
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9VAFD4hkKgbEF9cQByNCxaWtPNoO4kbgpKL3ovGcA0b08yLSLgphHu7YcVP4Df6SzwznVbxkRh3Tea003l8M9-cOQ-Aly4XhWHe_YzTIuFGisTvioksmJGpNFwFd7HxYT6c8HfH4ngBXne-MG18iF7h5pER1msPcK-Q_gnlajpFnDPvvbfkM3qHA9WnH8GjiqhhQQaRcMR1jCvk7Xj6V2_vRr9RzNuMNWw5-yvwpfvZ1tLkbKeZ6x1z9Uscx_9tzX1YjlyU7LaTZxUWXP0A7ozjbftDmOx9-Hzw5tv1TSbJaU0UscHcA9mpJZ0RVzMj8Y5nRr7GHCTkvJn7LKBk2Gh3Sj4GrYVxr0hI1v0IJvtvj_aGSUzDkBheUpkIxqWlkqvMsTxTWhQqNUKWRjvGVHHCkLI4JzIrLafc5ic201SXlpeWCZM69hgW6_ParQHhTEvJXYkkTHFbCClQPKWWaWHwk24A291wVCbGKPepMqZVd1bBbqpCNw3gRS960Qbm-JPQZjemVcTmrEJSQpEk5jQbwPO-GFHlr0pU7bDnKiQyokhLpFsDeNLOhb4WXAI9icOS7TCif6--2h2NwsP6v4s-g7vDo_GoGh0cvt-Ae9Qf74N18CYszi8b9xQ50Fxvhan-HTFx_mY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL2qilSxoUB5DBTqIhZdkCrxI4nFquowmsK0VIhBXSBFfo2oOkorZrJh1U_oN_IlXDtOaHlIiF0k38SxfY99bN8HwEuXi8Iw737GaZFwI0XiV8VEFszIVBqugrvY4VE-nvK3J-JkBV53vjBtfIj-wM0jI8zXHuAXdnYN5Go-R5gz77x3i-dp6VV6-OFn7KgiHrAggUg4wjqGFfJmPP2rNxej3xjmTcIaVpzROnzu_rU1NDnbbZZ613z7JYzjfzbmLtyJTJTstapzD1ZcfR_WDuNd-wZM999_Ohh-v7zKJDmtiSI2GHsgN7WkM-FqFiTe8CzIl5iBhJw3S58DlIwb7U7JcTizMO4VCam6H8B09Obj_jiJSRgSw0sqE8G4tFRylTmWZ0qLQqVGyNJox5gqZgwJi3Mis9Jyym0-s5mmurS8tEyY1LGHsFqf1-4xEM60lNyVSMEUt4WQAsVTapkWBj_pBrDTjUZlYoRynyhjXnU7FeymKnTTAF70ohdtWI4_CW12Q1pFZC4qpCQUKWJOswFs98WIKX9RomqHPVchjRFFWiLZGsCjVhX6WnAC9BQOS3bCgP69-mpvMgkPT_5ddAvWjoejanJw9O4p3KZ-bx9Mgzdhdfm1cc-QAC3186DoPwBRqf0e
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=COVID%E2%80%9019+in+a+designated+infectious+diseases+hospital+outside+Hubei+Province%2C+China&rft.jtitle=Allergy+%28Copenhagen%29&rft.au=Cai%2C+Qingxian&rft.au=Huang%2C+Deliang&rft.au=Ou%2C+Pengcheng&rft.au=Yu%2C+Hong&rft.date=2020-07-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0105-4538&rft.eissn=1398-9995&rft.volume=75&rft.issue=7&rft.spage=1742&rft.epage=1752&rft_id=info:doi/10.1111%2Fall.14309&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-4538&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-4538&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-4538&client=summon